Imaging and therapeutic radiotracers for prostate cancer
Radiotracers that target glutamate carboxypeptidase II, also known as the prostate specific membrane antigen (GCP(II)/PSMA), have shown exceptional promise for prostate cancer imaging and molecular radiotherapy. A number of bioconjugates have been developed to target GCP(II)/PSMA which utilise the s...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
King's College London (University of London)
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.762404 |